Browse diseases

… OPT-OMA-ASTHMA (EuCT-number: 2025-520782-48-00). Patients with severe asthma on stable omalizumab therapy who had achieved clinical remissio…

…spiratory morbidity and acute chest syndrome.1 However, data on asthma prevalence and screening strategies remain limited in tropical …

…th obstructive ventilatory impairment, particularly in COPD and asthma, whereas reactance-related parameters show stronger association…

…stic performance of COLA-6 for identifying CRDs—including COPD, asthma, preserved ratio impaired spirometry, restriction and overlaps—…

…Background The role of intravenous magnesium sulfate in asthma exacerbation is unclear.Aims To determine the efficacy and safety of intrave…

…y disease was the main CRD followed by asthma, sleep apnoea and interstitial lung disease. Overall, 6913 (17.3%) died at 1 year. Proportion of days alive…

…y from GPs. After CDC, 302 patients (45.2%) were diagnosed with asthma, 151 were diagnosed with COPD (22.6%) & 70 diagnosed with ACOS …

…r remission on treatment.2 Aim To analyse ability of real-world asthma patients on benralizumab to achieve the stringent American remi…

…ptoms of chronic respiratory diseases such as COPD, asthma, and interstitial lung disease. It impacts physical activity, mental health and quality of lif…

…ient triage.For the four priority chronic respiratory diseases (asthma, chronic obstructive pulmonary disease [COPD], bronchiectasis […

… potential use in the biological therapy of severe eosinophilic asthma. BioMed Research International 2018(1):4839230.…

…h patients. 1 Aims To measure outcomes of patients experiencing asthma exacerbations treated with a T2 biomarker guided strategy.Metho…